VRTX

VERTEX PHARMACEUTICALS INC / MA

Pharmaceutical Preparations · SIC 2834CIK 875320Held by 12 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

12 managers · Q2 2026 13F

13F bookWeight

Capital World Investors

Capital World InvestorsPosition history →

1.5%

+2.9%

$12.97B

$846.43B13F book · 2026-06-30

Tweedy Browne

Tweedy BrownePosition history →

1.5%

(0.7%)

$0.02B

$1.32B13F book · 2026-06-30

Capital Research Global Investors

Capital Research Global InvestorsPosition history →

1.4%

(7.7%)

$9.68B

$716.87B13F book · 2026-06-30

WCM Investment Management

WCM Investment ManagementPosition history →

1.0%

+2.7%

$0.58B

$55.16B13F book · 2026-06-30

Torray Funds

TorrayPosition history →

1.0%

(1.1%)

$0.01B

$0.74B13F book · 2026-06-30

Ashford Capital Management

Ashford Capital ManagementPosition history →

0.48%

—

$<0.01B

$0.93B13F book · 2026-06-30

Motley Fool Asset Management

Motley Fool Asset ManagementPosition history →

0.33%

(14.8%)

$0.01B

$2.59B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.27%

+56.3%

$0.20B

$71.32B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.22%

(24.1%)

$0.16B

$72.62B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.02%

(18.7%)

$0.01B

$24.38B13F book · 2026-06-30

Holocene Advisors

Holocene AdvisorsPosition history →

0.01%

(81.7%)

$0.01B

$43.69B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.01%

+116.8%

$<0.01B

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.